A new charter calls on the CDC's Advisory Committee on Immunization Practices (ACIP) to consider "non-vaccine interventions" and changes the focus, membership structure, and rules that govern the influential panel....

NEW YORK CITY -- People with aortic stenosis (AS) were increasingly getting timelier diagnosis, though treatment delays persisted in a national care quality registry study. U.S. patients flagged with moderate...

Diabetes patients using GLP-1 agents had a higher risk of smell and taste disturbances over 2 years, though absolute risk increases were very small.Smell disturbances included anosmia and parosmia; taste...

The Trump administration is moving to restart the specialized LGBTQ+ option for youth who contact the 988 crisis intervention hotline, but the group that helped pioneer the idea is being...

A European Medicines Agency (EMA) committee recommended pulling the marketing authorization for avacopan (Tavneos) following a review over data integrity concerns in the vasculitis drug's key supporting trial. Due to...

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up can...

Every day begins with scream therapy at Camp Breastie for breast cancer survivors. (New York Times) Comedian and actor Moshe Kasher, who appeared as a sign language interpreter in episodes...

AI smart eyeglasses showed some potential as an aid for individuals with low vision in a small pilot case series.The device excelled as an aid for recognizing common objects and...

The EMA approves a new formulation of a levodopa-carbidopa combination to treat moderate-to-severe motor fluctuations in patients with Parkinson’s disease. Medscape News Europe Source link : https://www.medscape.com/viewarticle/new-parkinsons-drug-combines-immediate-and-slow-release-2026a1000lux?src=rss Author : Publish...

uniQure may seek approval in the UK first while in talks with the FDA about its request for a larger, sham-controlled trial of the one-time, invasive gene therapy AMT-130. Medscape...

The EMA says the benefits of Tavneos no longer outweigh the risks for the treatment of active granulomatosis with polyangiitis. Medscape News Europe Source link : https://www.medscape.com/viewarticle/new-data-lead-decision-revoke-autoimmune-disease-drug-2026a1000lut?src=rss Author : Publish...

Europe will be reviewing the tuberculosis medication following concerns raised by the Dutch medicines agency. Medscape News Europe Source link : https://www.medscape.com/viewarticle/carcinogen-concerns-trigger-review-rifadin-syrup-2026a1000luq?src=rss Author : Publish date : 2026-06-26 15:44:00 Copyright...

The EMA reverses its previous decision and grants marketing authorization to the world’s first drug specifically approved for treating the syndrome. Medscape News Europe Source link : https://www.medscape.com/viewarticle/trofinetide-approved-rett-syndrome-after-reexamination-2026a1000lul?src=rss Author :...

Home-based human papillomavirus screening for cervical cancer shows modest uptake in a diverse community setting. Medscape Medical News Source link : https://www.medscape.com/viewarticle/racial-disparities-emerge-home-cervical-cancer-screening-2026a1000lrb?src=rss Author : Publish date : 2026-06-26 15:01:00 Copyright...

Tracy Hutchinson has a rare mutation of the TP53 geneTracy Hutchinson I started to wonder if something funky was going on when multiple people in my family got cancer around...

A federal judge has blocked part of a Trump administration plan that would have limited access to loans for students pursuing graduate degrees in nursing, physical therapy, public health, and...

Note that some links may require registration or subscription. Calling the disease "relentless," tennis legend Chris Evert said her ovarian cancer had returned for a third time. (People) The Supreme...

"Have yourself a good life." That was my friend's message informing me of his plan to end his life through physician-assisted suicide. His pancreatic cancer had progressed and was no...

A sample is collected from a rock art figure in Tebellín, SpainABAMIA ARKEOS-ALBERTO MARTÍNEZ VILLA Ancient human DNA can survive on cave walls and rock art for thousands of years,...

A post-marketing trial finds the oral antiviral achieves effective blood concentrations in at-risk children aged 6 years or older with mild-to-moderate COVID. Medscape Medical News Source link : https://www.medscape.com/viewarticle/pfizer-trial-backs-paxlovid-dose-high-risk-children-2026a1000lsp?src=rss Author...